Mettler-Toledo International (NYSE:MTD) CEO Patrick Kaltenbach Sells 2,000 Shares

Mettler-Toledo International, Inc. (NYSE:MTD) CEO Patrick Kaltenbach sold 2,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $1,462.50, for a total transaction of $2,925,000.00. Following the sale, the chief executive officer owned 3,670 shares in the company, valued at $5,367,375. The trade was a 35.27% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.

Mettler-Toledo International Price Performance

NYSE:MTD opened at $1,411.00 on Friday. Mettler-Toledo International, Inc. has a 12 month low of $946.69 and a 12 month high of $1,471.06. The firm has a market capitalization of $28.82 billion, a PE ratio of 35.73, a price-to-earnings-growth ratio of 4.19 and a beta of 1.41. The business’s fifty day moving average price is $1,332.61 and its 200 day moving average price is $1,245.99.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share for the quarter, topping the consensus estimate of $10.62 by $0.53. The business had revenue of $1.03 billion during the quarter, compared to the consensus estimate of $997.36 million. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The company’s revenue was up 7.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $10.21 EPS. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. As a group, equities analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Institutional Trading of Mettler-Toledo International

Hedge funds and other institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. increased its position in Mettler-Toledo International by 1.3% during the 3rd quarter. Vanguard Group Inc. now owns 2,591,173 shares of the medical instruments supplier’s stock worth $3,180,950,000 after purchasing an additional 34,466 shares during the period. Bank of New York Mellon Corp boosted its stake in shares of Mettler-Toledo International by 71.3% in the second quarter. Bank of New York Mellon Corp now owns 904,264 shares of the medical instruments supplier’s stock valued at $1,062,257,000 after buying an additional 376,419 shares in the last quarter. Capital International Investors grew its holdings in Mettler-Toledo International by 1.2% during the third quarter. Capital International Investors now owns 859,559 shares of the medical instruments supplier’s stock worth $1,055,203,000 after acquiring an additional 10,395 shares during the period. Alliancebernstein L.P. increased its holdings in shares of Mettler-Toledo International by 1.1% in the 2nd quarter. Alliancebernstein L.P. now owns 717,449 shares of the medical instruments supplier’s stock valued at $842,802,000 after purchasing an additional 8,121 shares in the last quarter. Finally, Geode Capital Management LLC increased its holdings in Mettler-Toledo International by 0.6% in the second quarter. Geode Capital Management LLC now owns 581,847 shares of the medical instruments supplier’s stock valued at $681,489,000 after buying an additional 3,383 shares in the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Analyst Upgrades and Downgrades

MTD has been the subject of several research reports. Wells Fargo & Company boosted their target price on Mettler-Toledo International from $1,200.00 to $1,400.00 and gave the company an “equal weight” rating in a report on Monday. Citigroup boosted their price objective on Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the company a “buy” rating in a research note on Monday. JPMorgan Chase & Co. raised their target price on shares of Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the stock a “neutral” rating in a research report on Thursday, October 9th. Stifel Nicolaus upped their price target on shares of Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the company a “buy” rating in a research report on Monday. Finally, Robert W. Baird increased their price target on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a “neutral” rating in a research note on Monday, August 4th. Five equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $1,406.50.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.